47 results
8-K
EX-99.1
0ymmjr
13 May 21
Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain for up to 72 Hours
8:25am
8-K
EX-99.2
ym03u5 7bnw50
11 Jan 21
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises and Announces New Development Program
8:40am
8-K
EX-99.2
pvge j4b1x9tuynoz3rl
13 Jan 20
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises
8:41am
8-K
EX-99.2
xe1r5fng0evb
2 Oct 19
Heron Announces Positive Topline Results from Phase 3b Clinical Study of HTX-011 in Total Knee Arthroplasty
7:57am
8-K
EX-99.2
j4anlp050 8l
7 Jan 19
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises
8:36am
8-K/A
EX-99.3
aqp214dcgboy6ohd122
25 Jun 18
Other Events
4:01pm
8-K
EX-99.3
r7a76x94hgj 8qg
21 Jun 18
Regulation FD Disclosure
8:11am